Navigating Medications Through Pregnancy: A Stage-by-Stage Guide for Expectant Mothers

For many women, the moment a pregnancy test turns positive is also the moment a wave of uncertainty washes over every pill bottle in the medicine cabinet. Questions multiply quickly: Is it safe to keep taking my blood pressure medication? Should I have stopped my antidepressant before trying to conceive? Can I nurse my newborn while still on a prescription?

These are not trivial concerns. Medication decisions during pregnancy carry real consequences—for the developing fetus, for the mother's health, and for the postpartum period that follows. Yet the information available to patients is often fragmented, overly technical, or contradictory. This guide is designed to bring clarity to each stage of the journey.

Before You Conceive: The Overlooked Window

Pre-conception is arguably the most underutilized opportunity for medication review. Many women do not schedule a pre-pregnancy consultation with their physician, which means that adjustments to potentially harmful drugs happen reactively—after conception—rather than proactively.

Several medications require weeks or even months to safely taper before pregnancy begins. Isotretinoin (commonly known by the brand name Accutane), used to treat severe acne, is one of the most well-documented teratogens—substances capable of causing fetal malformation. The FDA's iPLEDGE program mandates a mandatory waiting period and two forms of contraception for women of childbearing age who are prescribed this drug precisely because of its severe risks.

Other medications warrant similar advance planning:

• Valproic acid (used for epilepsy and bipolar disorder) is associated with neural tube defects and should be discussed with a neurologist or psychiatrist well before conception.
• Methotrexate (prescribed for rheumatoid arthritis and certain skin conditions) must be discontinued several months before attempting pregnancy.
• Warfarin (a blood thinner) can be replaced with safer anticoagulants under physician supervision.

The pre-conception window is also the right time to begin folic acid supplementation—ideally 400 to 800 micrograms daily—which significantly reduces the risk of neural tube defects during early fetal development.

Understanding the FDA's Pregnancy Labeling Framework

For decades, the FDA used a letter-based classification system (Categories A, B, C, D, and X) to communicate medication risk during pregnancy. Category A drugs had demonstrated safety in controlled human studies; Category X drugs carried risks that clearly outweighed any benefit.

In 2015, however, the FDA replaced this system with the Pregnancy and Lactation Labeling Rule (PLLR). Under this newer framework, drug labels now include three distinct sections: Pregnancy, Lactation, and Females and Males of Reproductive Potential. Each section provides a narrative summary of available data rather than a single letter grade.

This shift was made because the old letter system was frequently misinterpreted. Many patients and even some clinicians assumed that a Category C drug was automatically safer than a Category D drug, when in reality the categories reflected the type of available data as much as the actual level of risk. The PLLR approach encourages a more nuanced, individualized conversation between patient and provider.

When reviewing any medication during pregnancy, ask your pharmacist or physician to walk you through the current labeling language—not just a letter grade.

The First Trimester: When Risk Is Highest

The first twelve weeks of pregnancy represent the period of organogenesis—the formation of the fetus's major organ systems. It is during this window that exposure to teratogenic substances carries the greatest potential for structural birth defects.

Common medications that require particular caution during the first trimester include:

• NSAIDs such as ibuprofen and naproxen: While generally considered lower-risk in the first trimester, they are associated with increased miscarriage risk and should be used sparingly. They are more clearly contraindicated in the third trimester.
• ACE inhibitors (used for hypertension): Associated with fetal kidney damage, particularly in the second and third trimesters, but best avoided throughout pregnancy.
• Certain antidepressants: SSRIs are among the most studied psychiatric medications in pregnancy. Most are considered relatively safe, though paroxetine (Paxil) has been associated with cardiac defects and is generally avoided. Stopping antidepressants abruptly without medical guidance can also pose serious risks to maternal mental health.

Women managing chronic conditions—diabetes, epilepsy, thyroid disorders, asthma, or mental health conditions—should not discontinue medications without physician oversight. Untreated illness itself poses risks to fetal development.

The Second and Third Trimesters: Shifting Risks

As pregnancy progresses, fetal organ systems continue to mature, and medication risks shift accordingly. Some drugs that carry limited risk in early pregnancy become more problematic later.

Aspirin at low doses (81 mg) is actually recommended by many physicians to reduce the risk of preeclampsia in high-risk pregnancies—a striking example of how context determines safety. Yet standard-dose aspirin and other NSAIDs are associated with premature closure of the ductus arteriosus (a vital fetal blood vessel) when used in the third trimester.

Opioid medications, if used during pregnancy, require careful management. Neonatal opioid withdrawal syndrome (NOWS) is a well-documented condition in newborns exposed to opioids in utero. Women being treated for opioid use disorder with medications such as buprenorphine or methadone should not discontinue treatment without physician guidance—the risks of untreated addiction far exceed the manageable risks of medication-assisted treatment.

Over-the-Counter Medications: Not Automatically Safe

A common misconception is that medications available without a prescription are inherently safe during pregnancy. This is not accurate. Several widely used OTC products carry meaningful risks:

• Oral decongestants such as pseudoephedrine are generally avoided in the first trimester due to possible associations with certain birth defects.
• Bismuth subsalicylate (Pepto-Bismol) contains salicylate and is not recommended during pregnancy.
• Certain antacids containing sodium bicarbonate in high doses may affect fluid balance.

Acetaminophen (Tylenol) has long been considered the analgesic of choice during pregnancy, though emerging research has prompted some scientists to call for more cautious use. Current guidance still supports its use at the lowest effective dose for the shortest necessary duration.

When in doubt, consult your pharmacist before reaching for any OTC product during pregnancy.

Breastfeeding and Medications: The Postpartum Chapter

Delivery does not end the conversation about medication safety. Many drugs pass into breast milk, though the extent varies considerably by drug class, maternal dosage, and the age and health of the nursing infant.

The LactMed database, maintained by the National Institutes of Health, is a freely accessible resource that provides detailed, evidence-based information on drug transfer into human milk and potential effects on nursing infants. Both patients and providers can consult it when evaluating postpartum medication decisions.

Some medications considered safe during pregnancy require reassessment postpartum. Others that were avoided during pregnancy may be appropriate once breastfeeding ends or is not initiated. Timing of doses—taking medication immediately after nursing, for instance—can sometimes reduce infant exposure.

Postpartum mental health is a particularly sensitive area. Postpartum depression affects a significant percentage of new mothers, and the decision to begin or resume psychiatric medication while breastfeeding requires a careful, individualized risk-benefit discussion with a healthcare provider.

Working With Your Healthcare Team

No article—including this one—can substitute for a direct conversation with your obstetrician, midwife, pharmacist, or specialist. Every pregnancy is different, and every medication decision involves a balance of risks and benefits that is unique to your medical history.

Before or during pregnancy, consider requesting a formal medication review with your care team. Bring a complete list of every prescription, over-the-counter product, supplement, and herbal remedy you take. Ask specifically about each one. Do not assume that silence equals safety.

For patients managing complex chronic conditions, a coordinated conversation between your OB and your specialist—whether a cardiologist, psychiatrist, or rheumatologist—ensures that no critical clinical consideration falls through the cracks.

Medication decisions during pregnancy are among the most consequential a patient will ever make. With the right information and the right support, they do not have to be made in the dark.